In 1998, Grandis et al. demonstrated that the EGFR expression in human HNSCC was highly varied with a range of 5–233 % expression as compared to the “gold standard” A431 cell line [2]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.